Novel radioactive estratrienes

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 9, 424 85, 2603975, 26039745, 514182, A61K 4900, A61K 4300

Patent

active

046328203

ABSTRACT:
Novel radioactive .DELTA..sup.4,9,11 -estratrienes marked with iodine 125 or 131 having the formula ##STR1## wherein R is selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms and acyl of an organic carboxylic acid of 2 to 12 carbon atoms, R.sub.1 is the reminder of an amino acid of the formula R.sub.1 NH.sub.2 or a derivative thereof being marked with iodine 125 or 131 and the wavy lines indicate the --OR is in the .alpha.- or .beta.-position and the oximido group is in the syn or anti position, a process and intermediates for their preparation, antigens prepared therefrom and use thereof to prepare antibodies.

REFERENCES:
patent: 4323511 (1982-04-01), Varma et al.
patent: 4331646 (1982-05-01), Delaage
"Steroids" (1978) vol. 31, No. 3, pp. 393-406, article by Scott et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Novel radioactive estratrienes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel radioactive estratrienes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel radioactive estratrienes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1546667

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.